Home / Search Results

Search Results

You searched for:

A deep dive into 4 topics discussed during a series of interactive sessions at the ACCC 49th Annual Meeting and Cancer Center Business Summit: business and artificial intelligence technology, research and clinical trials, and precision medicine.
Carolina Blood and Cancer Care Associate's No One Left Alone (or NOLA) initiative is a multi-phase pilot program aimed at lessening disparities in cancer care in three key areas: care access, biomarker testing, and clinical trials.
Beginning January 2022, CMS will be required to cover for Medicaid patients the routine costs associated with participating in clinical trials. Learn what states and provider organizations can do to leverage this mandate to address barriers to care in the community and reduce inequities in clinical trial participation.
Montana is one of the most rural states in the U.S., with nearly half of its population living in rural regions. Accordingly, accessing healthcare services can be difficult for Montana’s citizens, and gaining access to clinical trials is particularly challenging.
In the final installment of ACCC’s webinar series honoring American Pharmacists Month, experts discussed the integral role pharmacists play in supporting clinical trial research in the community setting, and they identified opportunities for extending the pharmacist role in an increasingly complex research landscape.
At the risk of repeating a phrase that has been exhausted this year, the dawn of 2020 brought with it unprecedented times. Whereas a pandemic on its own would have dominated everything else, this year also brought on an economic depression; a racial awakening; record-breaking wildfires, hurricanes, and floods; political turmoil on an extraordinary scale; and a host of additional unique phenomena. …
Listed are my highlights of the ASCO 2020 abstracts, which were chosen if they were a practice-changing study or trial with important new advances.
In Louisiana, cancer incidence and death rates are greater than the national average. However, access to early phase clinical trials was nearly impossible to find. 2018 ACCC Innovator Award winner Ochsner Health System partnered with the Translational Genomics Research institute to establish a dedicated center to that accelerated treatment development and expanded patient access to precision …
In the Department of Pharmacy at the University of North Carolina North Carolina Cancer Hospital, discarding partial drug vials was a significant source of waste. With their Innovator Award–winning drug vial optimization program, the program maximized the lifespan of drugs within single-dose vials and realized an annual cost savings of more than $40 million.
CRISPR, a gene editing tool, has entered the scientific arena and public discourse at an astounding speed. Eric B. Kmiec, PhD, director of the Gene Editing Institute at the Helen F. Graham Cancer Center & Research Institute, discusses the emergence of gene editing, how it can be utilized as a tool in the battle against cancer, and the challenges facing its transition from bench to bedside.
In this guest blog post, learn how 2018 ACCC Innovator Award recipient Ochsner Health System, Ochsner Cancer Institute of New Orleans is helping cancer patients access early-phase clinical trials close to home. Age-adjusted mortality rates from cancer are higher in Louisiana than the national average. Every day, 70 Louisianans receive a cancer diagnosis, and 23 Louisianans die of cancer. In April …
Sometimes referred to as the “terminator,” glioblastoma (GBM) is one of the deadliest forms of brain cancer.
Extending precision cancer clinical trials to community cancer programs is a primary goal of the Oncology Research Information Exchange Network (ORIEN), a partnership of some of the leading NCI-designated Cancer Centers nationwide.